Filter Results:
(217)
Show Results For
- All HBS Web (351)
- Faculty Publications (142)
Show Results For
- All HBS Web (351)
- Faculty Publications (142)
Sort by
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
watch a series of real, crime-related videos (while the control group watches non-crime-related videos). Not previously victimized participants exposed to the treatment video show significant changes in cortisol level, heart rate, and... View Details
Keywords: Sean Silverthorne
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- 06 Apr 2015
- Research & Ideas
After Germanwings, More Attention Needed on Employee Mental Health
people? One possible answer came this past week when the airline revealed that the pilot, Andreas Lubitz, had previously suffered from deep depression. Debates began about how Lubitz's mental health played into the tragedy, what treatment... View Details
- 14 Jul 2006
- Op-Ed
The Case for Consumer-Driven Medicaid
diabetic and asthmatic enrollees due to increased testing and drug utilization, while management consulting firm McKinsey found that consumer-driven enrollees were more likely to "very carefully follow View Details
Keywords: by Regina E. Herzlinger
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 02 Jan 2020
- Op-Ed
Medicare for All or Public Option: Can Either Heal Health Care?
for All published by the Harvard Business Review. [Image: Hispanolistic] Related Reading Germany May Have the Answer for Reducing Drug Prices What Hospitals Must Learn to Compete Making Health Insurance That Consumers Actually Like What... View Details
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of... View Details
Keywords: by Julia Hanna
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
series on AIDS in Africa and how pharmaceutical companies should think about the issues and how they might respond. Sandra Sucher has done a really wonderful case on Gleevec, which is a drug for treating chronic myeloid leukemia. She is... View Details
- 16 Jul 2008
- Op-Ed
What Should Employers Do about Health Care?
frequently in search of a better deal, which has meant that their employees needed to switch as well. They have tried to pare back covered services, thrown up barriers to expensive drugs and treatments, and recently, begun to pass more... View Details
- 13 Jul 2009
- Research & Ideas
Diagnosing the Public Health Care Alternative
of its inadequate payments. In the end, the Democrats' health care reform will require drastic rationing of health care for the sick to control its costs. The government-controlled UK health care system points the way because it features, for example, the lowest uptake... View Details
- 19 Jun 2013
- Research & Ideas
Analyzing Institutions to Solve Big Problems
that marijuana was a popular treatment in the nineteenth century, and the drug was listed in the Dispensatory of the United States by the 1850s. The paper looks at how the Federal Bureau of Narcotics managed... View Details
Keywords: by Carmen Nobel & Anna Secino
- 28 Jul 2015
- First Look
First Look: July 28, 2015
of Dublin, Ireland-based Elan Drug Technologies (EDT)-a deal that was expected to close in the fall. The case describes the history of Alkermes, provides information about the planned merger, and details the funding options. The case... View Details
Keywords: Carmen Nobel
- 30 Mar 2010
- First Look
First Look: March 30
regulatory objections were debated and tensions rose between U.S. and EC regulators. Purchase this case:http://cb.hbsp.harvard.edu/cb/product/310086-PDF-ENG Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and... View Details
Keywords: Sean Silverthorne
- 08 Jun 2010
- First Look
First Look: June 8
had to be updated to enable collaboration. The current dilemma facing the CEO and COO of the foundation relates to setting strategic priorities for research so that a treatment for MS can be ready in the next ten years. The strategic... View Details
Keywords: Martha Lagace
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- 07 Aug 2007
- First Look
First Look: August 7, 2007
their dividend policy to serve their institutional shareholders. Download the paper: http://papers.nber.org/papers/W13283 Taxes and Portfolio Choice: Evidence from JGTRRA's Treatment of International Dividends Authors:Mihir A. Desai and... View Details
Keywords: Martha Lagace
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
potential for multiple breakthroughs related to the specific tumor segmentation task of radiation oncologists while also addressing technological issues (e.g., reframing and conducting sequential competition phases). Lagace: What made this problem in cancer View Details
- 27 Sep 2011
- First Look
First Look: September 27
(forthcoming) An abstract is unavailable at this time. The Variance of Non-Parametric Treatment Effect Estimators in the Presence of Clustering Authors:Samuel G. Hanson and Adi Sunderam Publication:The Review of Economics and Statistics... View Details
Keywords: Sean Silverthorne
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
and perhaps even refine them more. There's a growing movement and establishment of nonprofit foundations that are participating in drug discovery efforts. These foundations aren't as concerned about intellectual property as they are about... View Details
Keywords: by Martha Lagace
- 26 Sep 2006
- First Look
First Look: September 26, 2006
the pandemic. Most have not been very successful. An examination of three strategies for distributing antiretroviral drugs (ARVs) to patients in three countries on three continents, Africa, Asia, and South America, suggests a customer... View Details
Keywords: Sean Silverthorne